Search the Journal

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info


Read Full Text


Download PDF


View Table of Contents

Mannose Binding Lectin Levels in Spondyloarthropathies

SIBEL ZEHRA AYDIN, PAMIR ATAGUNDUZ, NEVSUN INANC, MUGE BICAKCIGIL, DEMET TASAN, MUSA TEMEL, and HANER DIRESKENELI

ABSTRACT.

Objective.
Mannose binding lectin (MBL), a member of the collectin family proteins, is a major molecule of the innate immune system; MBL deficiency is associated with increased susceptibility to infections. As gastrointestinal and genitourinary infections are suggested to be among the etiological factors of spondyloarthropathies (SpA), we investigated MBL deficiency in ankylosing spondylitis (AS) and undifferentiated SpA (uSpA).

Methods. One hundred seven patients with AS, 43 patients with uSpA, and 74 healthy controls were studied. Disease activity, radiological scores, and demographic features were recorded. MBL levels were measured with standard ELISA kits.

Results. Median MBL levels in AS, uSpA, and controls were 2705 (range 0–5861) ng/ml, 2897 (36–7586) ng/ml, and 3468 (0–7950) ng/ml, respectively. No significant differences were observed in median MBL levels and the prevalence of MBL deficiency between the groups. Bath AS Radiological Index scores were not affected by MBL levels. However, although statistically not significant, radiographic damage quantified by modified Stoke AS Spine Score (mSASSS) was 3 times higher in AS patients with MBL deficiency. Disease activity, clinical picture, and therapies were not associated with MBL levels.

Conclusion. In AS patients with MBL deficiency, there was a tendency towards a more severe radiographic progression detected by mSASSS. (First Release Sept 15 2007; J Rheumatol 2007;34:2075-7)

Key Indexing Terms:

SPONDYLOARTHROPATHIES
ANKYLOSING SPONDYLITIS
MANNOSE BINDING LECTINS


From the Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey.

S.Z. Aydin, MD; P. Atagunduz, MD; N. Inanc, MD; M. Bicakcigil, MD; D. Tasan, MD; M. Temel, MD; H. Direskeneli, MD, Marmara University Faculty of Medicine.

Address reprint requests to Dr. S.Z. Aydin, Rheumatology, Marmara University Faculty of Medicine, Tophanelioglu cad. 13/15, Altunizade, Istanbul 34660, Turkey. E-mail: drsibelaydin@gmail.com

Accepted for publication June 27, 2007.




Return to September 2007 Table of Contents



© 2007. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.